Assessing the Sensitivity of "SureTouch " in Identifying Clinically Significant Masses in Women Undergoing Diagnostic and Screening Mammography

  • STATUS
    Recruiting
  • participants needed
    195
  • sponsor
    Rebecca Kaltman, MD
Updated on 19 February 2024
screening mammography

Summary

Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.

Description

This is a single-center, prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.

Results of the mammography will be compared to the SureTouch examination results.

Subjects will have between 1 and 3 research visits and 3 follow-up surveys, up to two years from the initial visit. The number of visits will be based upon comparison of the SureTouch examination to conventional breast screening techniques (mammogram and ultrasound).

Details
Condition Breast Cancer, Breast Cancer
Age 30-80 years
Treatment SureTouch
Clinical Study IdentifierNCT04397029
SponsorRebecca Kaltman, MD
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Arm 1
Female Subject presenting for screening mammography
-80 years of age, inclusive
Able to provide written informed consent
Arm 2
Female Subject presenting for diagnostic appointment and/or biopsy
-80 years of age, inclusive
-3 masses per breast
Masses between 0.5 cm and 3.5 cm only

Exclusion Criteria

Individuals who are unable to comprehend or unwilling to sign an informed consent form
Women younger than 30 or older than 80
Pregnant women
Women who have undergone bilateral mastectomies
Males
Prisoners
Masses which are larger than 3.5 cm or smaller than 0.5 cm in size
Individuals with more than 3 masses per breast will be excluded due to the complexity of these cases
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.